Mild Radical Chemistry rau kev hloov peptide theem kawg

Q

h, o, v. It encodes specific operating parameters: ', m 37 °C, o, s, carboxyl, d, u, a, '. Published criteria for bioconjugation compatibility generally define this range explicitly, t.

i, a. g. HAT-based cascade methods and electrochemical C–H/S–H coupling methods can require co-solvents (typically DMSO/water mixtures) at ratios that affect solubility of longer or more aggregation-prone sequences. Directed C(sp³)–H arylation methods — particularly the palladium-catalyzed variants — impose additional constraints around directing group installation and removal, which adds steps and potential impurity sources. The question for any development team is not whether a method is “mild in principle” but whether it is mild enough for the specific sequence and downstream application.

Photoredox Conjugation: What the Evidence Supports

Photoredox catalysis has generated the largest and most reproducible body of late-stage peptide functionalization data. The core mechanism — exciting a photocatalyst with visible light, generating reactive radical intermediates at defined positions, and coupling them to radical acceptors or partners — offers chemoselectivity through the electronic selectivity of the excited-state catalyst rather than through protecting-group maneuvers.

Tryptophan as the primary handle. C2-alkylation and C2-sulfenylation of tryptophan-containing peptides have both been demonstrated under metal-free and photocatalyst-free conditions, the latter using arylthianthrenium salts. A 2023 report in Organic Letters (ACS, chemoselective late-stage functionalization via photocatalytic C2-alkylation of tryptophan) described functional group tolerance compatible with unprotected aspartate, glutamate, lysine, and serine side chains — which is the minimum bar for credible peptide late-stage functionalization. A 2024 clickable tryptophan modification described in Science Advances reported catalyst-free, C2-sulfenylation theem kawg uas tiv taus cysteine dawb residues, ib qho kev sim nyuaj heev ntawm chemoselectivity.

Histidine alkylation. Ib qho minisci-light pom tau C–H alkylation ntawm histidine-containing peptides siv 4-alkyl-1,4-dihydropyridines ua radical precursors tau tshaj tawm. Histidine feem ntau yog ib qho residue muaj teeb meem hauv photochemical vim nws oxidation susceptibility, yog li cov txheej txheem uas tau lees paub uas tsom rau imidazole C2 lossis C5 qhov chaw ntxiv ib qho tshuaj lom neeg txawv handle.

Dehydroalanine (Dha) ua ib qho radical acceptor ntau yam. Dha teeb tsa los ntawm enzymatically lossis los ntawm kev hloov tshuaj ntawm serine lossis cysteine ua haujlwm raws li Michael-type radical acceptor hauv ntau yam xwm txheej. A 2025 tsab ntawv ceeb toom txog site-selective construction ntawm N-linked glycopeptides los ntawm photoredox catalysis (PubMed) used Dha as the acceptor for N-glycosyl oxamic acid-derived radicals under visible light, demonstrating Giese-type addition without protecting the remaining glycine, alanine, or serine residues present. The yield and diastereoselectivity figures in that study — and the absence of a stereoselective solution for Dha radical additions in many earlier reports — highlight a persistent gap: radical addition to Dha is often not stereoretentive, which matters when the α-carbon configuration affects receptor binding or protease stability.

Decarboxylative conjugation. MacMillan’s group showed that the C-terminal carboxylate of peptides can be selectively oxidized and coupled through radical decarboxylation under blue light, exploiting the difference in oxidation potential between internal and terminal carboxylates. Txoj kev no yooj yim rau kev ua haujlwm thiab tsis tas yuav muaj kev tiv thaiv ua ntej ntawm side-chain, tab sis nws siv C-terminus — uas txwv nws qhov muaj txiaj ntsig tshwj tsis yog muaj kev tso tseg C-terminus dawb lossis lub hom phiaj yog cim npe kawg.

Daim ntawv qhia kev tsim kho: Photoredox txoj kev tau qhia txog kev ua haujlwm dav tshaj plaws hauv cov ntawv sau. Cov lus nug qhib rau kev siv yog tshem tawm reagents thiab photocatalysts, kev nyiam oxygen thaum ua tshuaj thiab ua haujlwm, thiab seb solvent systems (feem ntau DMSO/dej) puas haum nrog kev ntxuav thiab lyophilization tom qab yam tsis tso tseg cov seem ntev.

HAT and MHAT: Remote Activation Without Prefunctionalization

Hydrogen atom transfer (HAT) chemistry nyob hauv ib qho chaw txawv ntawm photoredox. Tsis yog tsom rau ib qho chaw ua haujlwm redox uas tau teeb tsa ua ntej, HAT-based methods abstracts hydrogen atoms los ntawm C(sp³)–H bonds to generate carbon-centered radicals at positions that would otherwise require directing groups or prefunctionalization. In the context of peptide modification, this primarily means two things: remote functionalization via 1,5-HAT relay processes and sequential cascade reactions combining radical generation with a second catalytic bond-forming step.

Peptide Synthesis A 2025 paper in Organic Chemistry Frontiers (RSC, three-component alkylation of glycine derivatives and peptides via a site-selective 1,5-HAT cascade) demonstrated visible-light-mediated N-centered radical generation followed by 1,5-hydrogen atom transfer to the α-carbon of glycine residues, enabling a three-component alkylation. The selectivity arises from the geometry of the 1,5-shift rather than from electronic preference for any particular side chain, which has both advantages and limitations: the approach is broadly applicable to glycine-containing sequences but does not inherently distinguish between similarly positioned residues in longer chains.

Metal-assisted HAT, sometimes referred to in its cobalt- or iron-mediated forms as MHAT, brings additional control. The metal hydride generates a carbon radical under mild conditions — typically room temperature, hydrogen or silane as hydrogen source — and the resulting radical can be trapped by an alkene or radical acceptor in the same flask. For peptide application, the relevant question is whether the metal catalyst and hydrogen-source reagent are compatible with histidine, methionine, and cysteine side chains, all of which are potential competing reaction partners. Published precedent exists for simple dipeptide and tripeptide substrates; validation at longer chain lengths with multiple reactive side chains remains limited in the primary literature as of mid-2026.

Daim ntawv qhia kev tsim kho: HAT and MHAT methods are attractive for modifying sequences where a natural radical handle (Cys, Trp, Dha) is absent or must be preserved for biological activity. The site-selectivity challenge is real and sequence-dependent — a short peptide where selectivity looks excellent may behave differently in a 20-residue sequence with multiple competing abstractable positions.

C(sp³)–H Functionalization: Backbone-Adjacent Editing

Directed C(sp³)–H functionalization represents the most ambitious arm of this chemistry for peptide applications, targeting internal backbone-adjacent positions without a traditional reactive handle. Two approaches have demonstrated preparative-scale potential on peptide substrates.

Side-chain-directed arylation. A 2024 study from Hou et al. — summarized in a 2026 RSC review (recent advances in site-specific modifications of peptides and proteins) — reported β-C(sp³)–H arylation of internal positions in both linear and cyclic peptides using S-alkyl cysteine as the directing group and 2-pyridone as an auxiliary ligand, under palladium catalysis. The method achieved arylation at the β-carbon of the residue adjacent to the cysteine-derived directing group under exceedingly mild conditions for a palladium-catalyzed C–H activation.

Backbone-inserted directing groups. A 2025 report in JACS (PubMed, Pd(II)-catalyzed C(sp³)–H functionalization directed by a removable, backbone-inserted amidoxime ether) described amidoxime ether insertion at any amide bond in the backbone, using it as a removable directing group for subsequent C(sp³)–H arylation. The amidoxime ether is installed and removed in separate synthetic steps, adding two transformations to the route — but the positional flexibility it provides has no equivalent in current standard modification approaches.

For sequence-agnostic positioning, this class is chemically significant. The practical burden — palladium removal, directing group installation and removal, SPPS-compatible protecting group compatibility, and potential epimerization at the α-carbon under palladium catalysis — is also the heaviest among the three transformation families discussed here.

Sulfur-Based Radical Methods: Chemoselectivity Backed by Data

Cysteine remains the most analytically tractable residue for site-selective peptide modification because its sulfur nucleophilicity and redox chemistry are sufficiently distinct from other side chains to allow clean reactions with appropriate electrophilic radical sources. Several 2024–2025 reports extend this toolkit in directions relevant to conjugation programs.

Aryl radicals generated from aryl pinacol boronates under mild aqueous conditions have been shown to perform selective S-arylation of peptides and proteins (aryl radicals from aryl pinacol boronates for peptide and protein modification, TU Darmstadt/Wiley). The selectivity for sulfur over aromatic amino acid side chains under aqueous, near-neutral conditions represents a meaningful advance over aryl diazonium salt chemistry, which is far less selective.

I, b, was described in t (x, 2025). o.

j, ADC-like conjugation, k, e.

Compatibility, Impurity, and Analytical Questions That Must Be Answered

C. o.

Compatibility Assessment

v, development teams should map the following:

Impurity Profile Prediction

Late-stage radical modification introduces a class of impurities distinct from SPPS-derived impurities. Expect and plan analytical methods for:

• Unreacted starting material: unconjugated peptide co-eluting nrog lossis ze rau cov khoom

• Cov hom uas hloov kho ntau dhau: yog muaj ntau tshaj ib qho chaw ua haujlwm (e.g., ob qho tryptophan residue nyob), cov khoom hloov ntau yuav tshwm sim ua cov cim hnyav siab dua ntawm ESI-MS lossis MALDI-TOF

• Regioisomeric products: rau Dha radical ntxiv lossis histidine alkylation, cov isomers chaw uas tsuas txawv hauv qhov chaw tsim kev sib txuas yuav tsis sib txawv los ntawm RP-HPLC xwb

• Cov khoom oxidation: cov xwm txheej radical tuaj yeem oxidize methionine mus rau sulfoxide lossis tryptophan mus rau oxindole — cov ntsiab lus uas ze rau cov khoom pib ntawm reverse-phase chromatography

• Catalyst-derived adducts: organic photocatalyst fragments, palladium residues (rau C–H functionalization), lossis reagent by-products los ntawm HAT co-reagents uas tsim adducts nrog peptide

Kev tswj hwm thiab CMC ntawm qhov chaw impurity no haum nrog EMA's Guideline on the Development and Manufacture of Synthetic Peptides, uas hais meej txog cov reagents txheej txheem, elemental impurities, thiab txoj kev tswj hwm rau synthetic intermediates.

Analytical Requirements

Standard RP-HPLC at 214 nm, uas ua haujlwm zoo rau SPPS impurity profiling, tsis txaus rau cov txiaj ntsig hloov kho kawg nkaus. Pab pawg yuav tsum npaj rau:

• LC-MS lossis LC-HRMS ua tus cim tseem ceeb — MS yuav tsum tau cais cov khoom pib tsis conjugated ntawm cov khoom mono-modified thaum lawv muaj chromatographic retention zoo sib xws

• Orthogonal chromatography modes (e.g., HILIC lossis IEX ntxiv rau RP) thaum regioisomers raug kwv yees; regioisomers nrog tib qho hnyav yuav tsis daws tau los ntawm mass detection xwb

• Amino acid analysis (AAA) for confirming that the amino acid composition after modification is consistent with a single addition event, not backbone cleavage or unusual side-chain loss

• Stability-indicating methods that can distinguish synthesis impurities (present in the initial batch) from degradation products that appear over time — critical when a radical modification step introduces new chromophores or functional groups that alter the oxidation or hydrolysis stability profile of the peptide

Scale-Up Engineering

Photoredox methods present the most technically specific scale-up challenges because photon delivery does not scale linearly. The incident light intensity at the center of a 1-liter flask is a fraction of that at the vessel surface, and lamp-to-reactor geometry determines conversion in a way that has no analogue in thermally driven chemistry. Flow chemistry reactors designed for photocatalysis address this through thin-film or flow-through irradiation, and several validated reactor designs now exist for pharmaceutical process development — but they require upfront capital and method re-optimization at each scale step.

HAT and electrochemical methods have different scale-up profiles. Electrode surface area scales more predictably than photon delivery, but electrochemical methods introduce questions about electrode materials compatibility, electrolyte removal, and current density uniformity at preparative scale.

For all transformation classes, the transition from analytical-scale HPLC purification to preparative HPLC introduces additional resolution challenges. A late-stage modification product co-eluting with mono-modified regioisomers at analytical scale will require careful re-optimization of gradient slope, mobile phase composition, and column chemistry at preparative loading — and preparative HPLC recovery from a complex mixture is the rate-limiting step in peptide scale-up more often than the synthesis itself.

A Framework for Evaluating Adoption Feasibility

Rather than adopting any of these methods wholesale, development teams should run a structured feasibility assessment tied to the specific modification target. The following decision matrix reflects the compatibility and risk dimensions discussed above.

Passing the full checklist does not guarantee success — but it identifies which experiments to prioritize before committing development resources. A failed compatibility screen at the 5-milligram scale saves far more time than the same failure at 100 milligrams during a late CRO run.

Where Conjugation Platforms Already Available Can Help

Programs evaluating these newer methods alongside existing, validated modification approaches will naturally reference what their synthesis partner can execute without a custom process development phase. Peptide modification platforms that routinely handle click chemistry handles (azides, maleimides, alkynes), glycopeptide installation, thiab fluorescent or isotope label conjugation already operate within the functional group tolerance envelope that radical late-stage methods are working to expand.

Q, h. o, v.

For everything else, m u a, j.

Questions the Field Has Not Yet Answered

To close with an honest inventory: t. x, i:

1. a: how conversion and selectivity behave at 100 milligrams versus 1 gram versus 100 grams under process-realistic conditions, with proper oxygen exclusion and temperature control

2. Stereoselectivity at Dha: radical addition to dehydroalanine generates a new α-center with variable diastereomeric ratio; this is an open problem, and the recent ChemBioChem review (advances in dehydroalanine-specific modification, 2025) explicitly flags it as unresolved for most substrate classes

3. Regulatory precedent: none of these routes has, to public knowledge, been the subject of a CMC IND section covering impurity qualification, genotoxic impurity assessment of photocatalyst residues, or stability-indicating method validation for radical-modified API — the groundwork remains to be laid

4. Long-term stability of the modification bond: radical additions to Dha, Trp, and His create C–C, C–S, los yog C–N bonds uas muaj kev ruaj khov sib txawv; cov ntaub ntawv kev ruaj khov tsawg rau feem ntau conjugate

Cov no tsis yog laj thawj los tshem tawm chemistry. Lawv yog qhov kev sim thiab kev tswj hwm uas yuav tsum tsim ua ke nrog txhua qhov kev txiav txim siab los muab cov txheej txheem no rau hauv kev tsim kho kev kho mob.

Practical Next Steps for Development Teams

Rau pab pawg uas tab tom tshuaj xyuas seb kev ua haujlwm radical me me thaum kawg puas tsim nyog rau lawv txoj kev hloov kho, cov kev ua tau zoo tshaj plaws rau lub sijhawm luv yog:

• Ua kom muaj kev sim me me (5–10 mg) nrog kev txiav txim zoo, tsom rau hom residue tshwj xeeb, nyob rau hauv cov xwm txheej radical uas tau muab — nrog LC-HRMS kev txheeb xyuas ntawm crude mixture, tsis yog tsuas yog HPLC purity

• Thov cov ntaub ntawv ruaj khov ntawm radical adduct bond hauv pH extremes, oxidative stress, and thermal stress before designing a purification method

• Map the impurity profile of the crude against what your preparative HPLC system can resolve, using spiked reference standards if available

• Identify whether regulatory precedent for the catalyst or reagent class exists in published IND CMC summaries, FDA guidance documents, or EMA assessment reports

The chemistry is moving fast. The analytical and process development infrastructure to use it responsibly in a development program takes longer to build. Starting that construction now, on a well-defined target sequence, is the right approach.

k supports development teams navigating complex modification requirements across more than 300 functional group transformation types, including click chemistry conjugation, glycopeptide synthesis, and isotope-labeled peptide production within a Class 100 sterile manufacturing environment. If your program involves modification positions or conjugation targets that fall outside standard SPPS workflows, a technical feasibility discussion is a practical starting point.